<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250325181104&amp;fc=20230708114047&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250325181104&amp;fc=20230708114047&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 25 Mar 2025 22:11:06 +0000</lastbuilddate>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>CCTA-Derived Coronary Plaque Burden Offers Enhanced Prognostic Value Over CAC Scoring In Suspected CAD Patients</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131307/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: AI-driven assessment of coronary plaque burden enhances prognostic accuracy for future adverse cardiovascular events, highlighting the critical role of comprehensive plaque characterization in refining risk stratification strategies.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Cardiovasc Imaging. 2025 Mar 25:jeaf093. doi: 10.1093/ehjci/jeaf093. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: To assess the prognostic utility of coronary artery calcium (CAC) scoring and coronary computed tomography angiography (CCTA) - derived quantitative plaque metrics for predicting adverse cardiovascular outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: The study enrolled 2,404 patients with suspected CAD but without prior history of CAD. All participants underwent CAC scoring and CCTA, with plaque metrics quantified using an artificial intelligence (AI)-based tool (Cleerly, Inc). Percent atheroma volume (PAV) and non-calcified plaque volume percentage (NCPV%), reflecting total plaque burden and the proportion of non-calcified plaque volume normalized to vessel volume, were evaluated. The primary endpoint was a composite of all-cause mortality and non-fatal myocardial infarction (MI). Cox proportional hazards models, adjusted for clinical risk factors and early revascularization, were employed for analysis.During a median follow-up of 7.0 years, 208 patients (8.7%) experienced the primary endpoint, including 73 cases of MI (3%). The model incorporating PAV demonstrated superior discriminatory power for the composite endpoint (AUC = 0.729) compared to CAC scoring (AUC = 0.706, p = 0.016). In MI prediction, PAV (AUC = 0.791) significantly outperformed CAC (AUC = 0.699, p &lt; 0.001), with NCPV% showing the highest prognostic accuracy (AUC = 0.814, p &lt; 0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: AI-driven assessment of coronary plaque burden enhances prognostic accuracy for future adverse cardiovascular events, highlighting the critical role of comprehensive plaque characterization in refining risk stratification strategies.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131307/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131307</a> | DOI:<a href=https://doi.org/10.1093/ehjci/jeaf093>10.1093/ehjci/jeaf093</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131307</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Jorge Dahdal</dc:creator>
<dc:creator>Ruurt A Jukema</dc:creator>
<dc:creator>Teemu Maaniitty</dc:creator>
<dc:creator>Nick S Nurmohamed</dc:creator>
<dc:creator>Pieter G Raijmakers</dc:creator>
<dc:creator>Roel Hoek</dc:creator>
<dc:creator>Roel S Driessen</dc:creator>
<dc:creator>Jos W R Twisk</dc:creator>
<dc:creator>Sara Bär</dc:creator>
<dc:creator>R Nils Planken</dc:creator>
<dc:creator>Niels van Royen</dc:creator>
<dc:creator>Robin Nijveldt</dc:creator>
<dc:creator>Jeroen J Bax</dc:creator>
<dc:creator>Antti Saraste</dc:creator>
<dc:creator>Alexander R van Rosendael</dc:creator>
<dc:creator>Paul Knaapen</dc:creator>
<dc:creator>Juhani Knuuti</dc:creator>
<dc:creator>Ibrahim Danad</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal. Cardiovascular Imaging</dc:source>
<dc:title>CCTA-Derived Coronary Plaque Burden Offers Enhanced Prognostic Value Over CAC Scoring In Suspected CAD Patients</dc:title>
<dc:identifier>pmid:40131307</dc:identifier>
<dc:identifier>doi:10.1093/ehjci/jeaf093</dc:identifier>
</item>
<item>
<title>Understanding the Cardiovascular Impacts of Heatwaves: Moving Beyond Simple Definitions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131260/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Mar 17:S0735-1097(25)00365-1. doi: 10.1016/j.jacc.2025.02.012. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131260/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131260</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.02.012>10.1016/j.jacc.2025.02.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131260</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Lingzhi Chu</dc:creator>
<dc:creator>Kai Chen</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Understanding the Cardiovascular Impacts of Heatwaves: Moving Beyond Simple Definitions</dc:title>
<dc:identifier>pmid:40131260</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.02.012</dc:identifier>
</item>
<item>
<title>Nonlinear Relation Between Cardiac Mortality and Excess Temperature in Heatwaves: Exposure Response in 2.39 Million Patients</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131259/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The heatwave-HD relationships show nonlinear trends with risk thresholds for daytime-only and nighttime-only heatwaves, but a near-linear pattern for compound heatwaves. Amid global warming, the use of a traditional binary definition could underestimate the mortality risk and burden of HD patients associated with heatwaves. These findings highlight the need for disease-specific health care measures tailored to different heatwave types to better manage cardiac risks in a warming...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Mar 13:S0735-1097(25)00339-0. doi: 10.1016/j.jacc.2025.01.034. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Short-term exposure to heatwaves has been associated with elevated heart disease (HD) mortality; however, the exposure-response relationship curves remain unexplored due to conventional binary heatwave definitions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study aimed to explore exposure-response curves for the associations between heatwaves and mortality from various cardiac causes using excess cumulative temperatures in heatwaves (ECT-HW).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This nationwide, individual-level, case-crossover study collected HD death records of all individuals across Mainland China from 2013 to 2019. We first defined daytime-only, nighttime-only, and day-night compound heatwaves using a bivariate approach, and then calculated the ECT-HW metric. We applied conditional logistic regressions with distributed lag nonlinear models to explore exposure-response curves, which were then used to estimate the corresponding mortality burden. Effects estimated using the traditional binary heatwave definition were compared with those derived from our ECT-HW metric.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We evaluated 2,392,254 HD deaths. Mortality risks associated with compound heatwaves exhibited a steady increase across the entire range of ECT-HW, without discernible thresholds. By contrast, risks from nighttime-only heatwaves emerged beyond the 25th percentile of ECT-HW and stabilized after the 90th percentile, whereas risks from daytime-only heatwaves plateaued between the 50th and 95th percentiles before rising again. Compound heatwaves demonstrated a significantly higher HD mortality risk (OR: 1.86) than nighttime-only (OR: 1.16) and daytime-only (OR: 1.19) heatwaves. A total of 41,869, 9,092, and 9,809 excess cardiac deaths were estimated to be associated with compound, nighttime-only, and daytime-only heatwaves, accounting for 1.75%, 0.38%, and 0.41% of total HD deaths, respectively. These estimates exceeded those derived from the traditional heatwave metric, which were 27,036, 2,871, and 4,785, respectively. Sudden cardiac arrest, acute myocardial infarction, and heart failure showed the highest sensitivity to compound heatwaves, whereas pulmonary heart disease exhibited the lowest.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The heatwave-HD relationships show nonlinear trends with risk thresholds for daytime-only and nighttime-only heatwaves, but a near-linear pattern for compound heatwaves. Amid global warming, the use of a traditional binary definition could underestimate the mortality risk and burden of HD patients associated with heatwaves. These findings highlight the need for disease-specific health care measures tailored to different heatwave types to better manage cardiac risks in a warming climate.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131259/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131259</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.034>10.1016/j.jacc.2025.01.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131259</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Xue Yu</dc:creator>
<dc:creator>Jiangdong Liu</dc:creator>
<dc:creator>Peng Yin</dc:creator>
<dc:creator>Ya Gao</dc:creator>
<dc:creator>Cheng He</dc:creator>
<dc:creator>Haidong Kan</dc:creator>
<dc:creator>Maigeng Zhou</dc:creator>
<dc:creator>Yong Huo</dc:creator>
<dc:creator>Renjie Chen</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Nonlinear Relation Between Cardiac Mortality and Excess Temperature in Heatwaves: Exposure Response in 2.39 Million Patients</dc:title>
<dc:identifier>pmid:40131259</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.034</dc:identifier>
</item>
<item>
<title>The Fontan Adult Brompton clinical score and mortality risk</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131022/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This novel, readily available, externally validated, clinical score identifies adult patients with a Fontan palliation at risk of mortality or transplantation and can be applied towards personalized care in this growing population with complex congenital heart disease.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf137. doi: 10.1093/eurheartj/ehaf137. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Adults with congenital heart disease who underwent a Fontan palliation are at increased risk of premature death. This study aimed to identify a risk score based on widely available clinical variables at the first adult visit and facilitate personalized care.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A single tertiary centre retrospective study included adults with a Fontan circulation during their first adults with congenital heart disease outpatient visit. Anatomic and periprocedural data, clinical, laboratory, and echocardiographic parameters at the first visit, and mortality or heart transplantation data were examined. A stepwise backward conditional approach was used to build a multivariate prognostic model, validated in an external retrospective cohort.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Overall, 230 patients (49.6% female), the median age of 21.7 [interquartile range (IQR) 18.7-28.0] years, were included. Within 10.2 years of follow-up, 44 patients died and two received heart transplantation. A score including age at the first visit, history of atrial tachyarrhythmia, heart failure, New York Heart Association class, systolic blood pressure, and resting arterial oxygen saturation was derived, discriminating patients into low, intermediate, and high risk of death or transplantation [C-index: 0.71, 95% confidence interval (CI) 0.62-0.80]; discriminative ability was excellent (C-index 0.92, 95% CI 0.90-0.95) when externally validated in a cohort of 80 patients [41.2% female, median age 18.4 (IQR 17.3-24.8) years] with similar freedom from transplantation survival with the derivation cohort (log-rank P = .77).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This novel, readily available, externally validated, clinical score identifies adult patients with a Fontan palliation at risk of mortality or transplantation and can be applied towards personalized care in this growing population with complex congenital heart disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131022/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131022</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf137>10.1093/eurheartj/ehaf137</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131022</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Claudia Montanaro</dc:creator>
<dc:creator>Alexandra Arvanitaki</dc:creator>
<dc:creator>William Kerrigan</dc:creator>
<dc:creator>Zehra Kadani</dc:creator>
<dc:creator>Rosaria Barracano</dc:creator>
<dc:creator>Giancarlo Scognamiglio</dc:creator>
<dc:creator>Aleksander Kempny</dc:creator>
<dc:creator>Wei Li</dc:creator>
<dc:creator>Margarita Brida</dc:creator>
<dc:creator>Ella McDonnell</dc:creator>
<dc:creator>Hajar Habibi</dc:creator>
<dc:creator>Konstantinos Dimopoulos</dc:creator>
<dc:creator>Isma Rafiq</dc:creator>
<dc:creator>Heng Ee Ling</dc:creator>
<dc:creator>Harith Alam</dc:creator>
<dc:creator>Berardo Sarubbi</dc:creator>
<dc:creator>Gerhard-Paul Diller</dc:creator>
<dc:creator>Michael A Gatzoulis</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The Fontan Adult Brompton clinical score and mortality risk</dc:title>
<dc:identifier>pmid:40131022</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf137</dc:identifier>
</item>
<item>
<title>Weekly Journal Scan: Uncoupling thrombosis from hemostasis in atrial fibrillation? An AZALEA surfing over troubled water</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131021/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf145. doi: 10.1093/eurheartj/ehaf145. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131021/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131021</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf145>10.1093/eurheartj/ehaf145</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131021</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Mattia Galli</dc:creator>
<dc:creator>Carlo Patrono</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly Journal Scan: Uncoupling thrombosis from hemostasis in atrial fibrillation? An AZALEA surfing over troubled water</dc:title>
<dc:identifier>pmid:40131021</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf145</dc:identifier>
</item>
<item>
<title>Routine left atrial appendage surgical closure for all patients undergoing cardiac surgery?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131020/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf122. doi: 10.1093/eurheartj/ehaf122. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131020/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131020</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf122>10.1093/eurheartj/ehaf122</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131020</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Andrea Colli</dc:creator>
<dc:creator>Laura Besola</dc:creator>
<dc:creator>Raffaele De Caterina</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Routine left atrial appendage surgical closure for all patients undergoing cardiac surgery?</dc:title>
<dc:identifier>pmid:40131020</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf122</dc:identifier>
</item>
<item>
<title>Less harmful alternative for smoking: addressing concerns on the observational study of electronic cigarettes and cardiovascular outcomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131016/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf153. doi: 10.1093/eurheartj/ehaf153. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131016/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131016</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf153>10.1093/eurheartj/ehaf153</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131016</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Danbee Kang</dc:creator>
<dc:creator>Ki Hong Choi</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Less harmful alternative for smoking: addressing concerns on the observational study of electronic cigarettes and cardiovascular outcomes</dc:title>
<dc:identifier>pmid:40131016</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf153</dc:identifier>
</item>
<item>
<title>Increasing heart rate in heart failure with preserved ejection fraction: a sensible way to go?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131014/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf109. doi: 10.1093/eurheartj/ehaf109. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131014/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131014</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf109>10.1093/eurheartj/ehaf109</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131014</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Payel Sen</dc:creator>
<dc:creator>Oana Sorop</dc:creator>
<dc:creator>Daphne Merkus</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Increasing heart rate in heart failure with preserved ejection fraction: a sensible way to go?</dc:title>
<dc:identifier>pmid:40131014</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf109</dc:identifier>
</item>
<item>
<title>Coffee drinking timing patterns and 'time-based' dietary patterns</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131013/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf155. doi: 10.1093/eurheartj/ehaf155. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131013/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131013</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf155>10.1093/eurheartj/ehaf155</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131013</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Lu Qi</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Coffee drinking timing patterns and 'time-based' dietary patterns</dc:title>
<dc:identifier>pmid:40131013</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf155</dc:identifier>
</item>
<item>
<title>Rate acceleration in heart failure with preserved ejection fraction: towards different strokes for different folks</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131011/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf110. doi: 10.1093/eurheartj/ehaf110. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131011/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131011</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf110>10.1093/eurheartj/ehaf110</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131011</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Tim van Loon</dc:creator>
<dc:creator>Kevin Vernooy</dc:creator>
<dc:creator>Joost Lumens</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Rate acceleration in heart failure with preserved ejection fraction: towards different strokes for different folks</dc:title>
<dc:identifier>pmid:40131011</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf110</dc:identifier>
</item>
<item>
<title>Timing of coffee consumption and mortality: a critical perspective</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131006/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf154. doi: 10.1093/eurheartj/ehaf154. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131006/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131006</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf154>10.1093/eurheartj/ehaf154</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131006</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Fan Zhang</dc:creator>
<dc:creator>Chang Liu</dc:creator>
<dc:creator>Min Cao</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Timing of coffee consumption and mortality: a critical perspective</dc:title>
<dc:identifier>pmid:40131006</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf154</dc:identifier>
</item>
<item>
<title>Weekly Journal Scan: Is there adequate evidence for targeting only one pathway of platelet activation shortly after an acute coronary syndrome?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40131005/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf146. doi: 10.1093/eurheartj/ehaf146. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40131005/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40131005</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf146>10.1093/eurheartj/ehaf146</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40131005</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:creator>Carlo Patrono</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly Journal Scan: Is there adequate evidence for targeting only one pathway of platelet activation shortly after an acute coronary syndrome?</dc:title>
<dc:identifier>pmid:40131005</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf146</dc:identifier>
</item>
<item>
<title>A case of multiple embryonal rhabdomyosarcoma in left atrium</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130997/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf147. doi: 10.1093/eurheartj/ehaf147. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130997/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130997</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf147>10.1093/eurheartj/ehaf147</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130997</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Jinping Li</dc:creator>
<dc:creator>Hongyu Huang</dc:creator>
<dc:creator>Fengxu Yu</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A case of multiple embryonal rhabdomyosarcoma in left atrium</dc:title>
<dc:identifier>pmid:40130997</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf147</dc:identifier>
</item>
<item>
<title>Weekly Journal Scan: SCOT-HEART and the PROMISE of a long-term impact of coronary computed tomography angiography on the care of patients with suspected angina</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130994/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf161. doi: 10.1093/eurheartj/ehaf161. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130994/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130994</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf161>10.1093/eurheartj/ehaf161</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130994</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly Journal Scan: SCOT-HEART and the PROMISE of a long-term impact of coronary computed tomography angiography on the care of patients with suspected angina</dc:title>
<dc:identifier>pmid:40130994</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf161</dc:identifier>
</item>
<item>
<title>Prognosis after switching to e-cigarettes: methods raise doubt about conclusion</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130987/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 25:ehaf152. doi: 10.1093/eurheartj/ehaf152. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130987/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130987</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf152>10.1093/eurheartj/ehaf152</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130987</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Harold J Farber</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Prognosis after switching to e-cigarettes: methods raise doubt about conclusion</dc:title>
<dc:identifier>pmid:40130987</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf152</dc:identifier>
</item>
<item>
<title>XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130322/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: We demonstrate a cardioprotective mechanism regulating myocardial lipid homeostasis. The findings provide a promising therapeutic target to prevent and treat HfpEF, a condition with limited treatment options.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25. doi: 10.1161/CIRCULATIONAHA.124.072194. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Morbidity and mortality of heart failure with preserved ejection fraction (HFpEF) is increased in metabolic disorders. However, options for preventing and treating these prevalent outcomes are limited. Intramyocardial lipotoxicity contributes to cardiac dysfunction. Here, we investigate the mechanisms underlying endoplasmic reticulum degradation enhancing EDEM2 (endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2) regulation of cardiac lipid homeostasis and assess strategies that inhibit the incidence and progression of HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Metabolic stress was induced in C57BL/6 male mice using a high-fat diet and Nω-nitro-l-arginine methyl ester. The recombinant adeno-associated virus 9 delivery system was used for loss- and gain-of-function studies. Palmitic acid and oleic acid stimulation of rat cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes imitated a condition of high lipids in vitro. Molecular mechanisms were investigated via RNA sequencing, mass spectrometry proteomics, lipidomic analyses, transmission electron microscopy, histology, and luciferase reporter assays.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In the human heart, we first detected lipid overload accompanied by a reduction of XBP1 (X-box binding protein 1) under metabolic stress. Thereafter, a decrease in EDEM2 was confirmed in human and mouse HFpEF hearts. Given that the spliced form of XBP1 (XBP1s) is a transcription factor, EDEM2 was identified as its new target in cardiomyocytes. EDEM2 knockdown mice manifested lipid droplet accumulation and higher levels of triglycerides and diglycerides in the myocardium, aggravating oxidative stress, hypertrophy, and the onset and progression of HFpEF under metabolic stress. XBP1s ablation mice displayed a similar myocardial lipid disturbance and cardiac phenotypes, which were reversed by EDEM2 overexpression. Mechanistically, the findings obtained from rat cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes demonstrated that, in the presence of EDEM2, SEC23A mediated intracellular translocation of ATGL (adipose triglyceride lipase) under fatty acid stimulation, inhibiting ATGL degradation and excessive intracellular lipid droplets. Furthermore, the functional studies supported that EDEM2 prevention of lipid overload occurred in an ATGL-dependent manner. Therapeutically, cardiac XBP1s or EDEM2 restoration mitigated lipid deposition and preserved lipid profiles in the myocardium, thus preventing the development of HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We demonstrate a cardioprotective mechanism regulating myocardial lipid homeostasis. The findings provide a promising therapeutic target to prevent and treat HfpEF, a condition with limited treatment options.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130322/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130322</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072194>10.1161/CIRCULATIONAHA.124.072194</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130322</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Oveena Fonseka</dc:creator>
<dc:creator>Rida Raja</dc:creator>
<dc:creator>Claire Ross</dc:creator>
<dc:creator>Sanskruti R Gare</dc:creator>
<dc:creator>Jiayan Zhang</dc:creator>
<dc:creator>Susanne S Hille</dc:creator>
<dc:creator>Katharine King</dc:creator>
<dc:creator>Andrea Ruiz-Velasco</dc:creator>
<dc:creator>Namrita Kaur</dc:creator>
<dc:creator>Xinyi Chen</dc:creator>
<dc:creator>Jessica M Miller</dc:creator>
<dc:creator>Riham R E Abouleisa</dc:creator>
<dc:creator>Qinghui Ou</dc:creator>
<dc:creator>Zhiyong Zou</dc:creator>
<dc:creator>Xiangjun Zhao</dc:creator>
<dc:creator>Cristian Sotomayor-Flores</dc:creator>
<dc:creator>Derk Frank</dc:creator>
<dc:creator>Eileithyia Swanton</dc:creator>
<dc:creator>Martin R Pool</dc:creator>
<dc:creator>Sara Missaglia</dc:creator>
<dc:creator>Daniela Tavian</dc:creator>
<dc:creator>Gabriele G Schiattarella</dc:creator>
<dc:creator>Tao Wang</dc:creator>
<dc:creator>Luigi Venetucci</dc:creator>
<dc:creator>Christian Pinali</dc:creator>
<dc:creator>Martin K Rutter</dc:creator>
<dc:creator>Bernard D Keavney</dc:creator>
<dc:creator>Elizabeth J Cartwright</dc:creator>
<dc:creator>Tamer M A Mohamed</dc:creator>
<dc:creator>Oliver J Müller</dc:creator>
<dc:creator>Wei Liu</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity</dc:title>
<dc:identifier>pmid:40130322</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072194</dc:identifier>
</item>
<item>
<title>Local DIO2 Elevation Is an Adaption in Malformed Cerebrovasculature</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130314/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: We delineate a novel DIO2-mediated adaption in malformed cerebrovasculature and conclude that targeting TH signaling may represent a potential therapy for cerebrovascular disorders.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 25. doi: 10.1161/CIRCRESAHA.124.325857. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Cerebrovascular malformations are a pivotal cause of hemorrhage and neurological disability alongside lacking effective medication. Thyroid hormones (THs), including thyroxine and triiodothyronine, are essential for vascular development, yet whether they participate in malformed cerebrovascular pathology remains elusive.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Single-cell transcriptome analysis characterized human cerebral cavernous malformations and brain arteriovenous malformations, 2 typical cerebrovascular malformation diseases. Adeno-associated virus-mediated DIO2 (iodothyronine deiodinase 2; an enzyme that converts thyroxine to active triiodothyronine) overexpression/knockdown or triiodothyronine/methimazole (an antithyroid drug) treatment was applied to mouse models of cerebral cavernous malformations (endothelial-specific <i>Pdcd10</i> knockout mice, <i>Pdcd10</i> KO) and brain arteriovenous malformations (endothelial-specific <i>Kras</i><sup><i>G12D</i></sup> mutant mice, <i>Kras</i><sup><i>G12D</i></sup>) to evaluate the involvement of DIO2 and TH signaling in cerebrovascular malformations.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: TH signaling was markedly activated in fibroblasts of human cerebral cavernous malformation and arteriovenous malformation single-cell samples, accompanied by elevated DIO2 expression. Similar DIO2 upregulation was observed in cerebrovascular fibroblasts of <i>Pdcd10</i> KO/<i>Kras</i><sup><i>G12D</i></sup> mice and patient brain sections. Exogenous DIO2 or triiodothyronine replenishment effectively reduced brain hemorrhage, excessive ECM (extracellular matrix) remodeling, and vascular leakage in juvenile and adult male and female <i>Pdcd10</i> KO/<i>Kras</i><sup><i>G12D</i></sup> mice. In contrast, DIO2 silencing or TH inhibition deteriorated vascular anomalies. Mechanistically, transcription factor Foxk1 (forkhead box K1) was determined to interact with the <i>DIO2</i> promoter region. The activation of fibroblast PI3K-Akt-mTOR signaling in <i>Pdcd10</i> KO/<i>Kras</i><sup><i>G12D</i></sup> mice triggered Foxk1 nuclear translocation to promote <i>DIO2</i> transcription. Triiodothyronine treatment mitigated inflammatory infiltration, normalized mitochondrial morphology, and restored mitochondrial biogenesis in malformed brain vessels by activating the Pgc1a (peroxisome proliferator-activated receptor gamma coactivator 1-alpha)-Sod2 (superoxide dismutase 2)/Prdx3 (peroxiredoxin 3)/Gpx1 (glutathione peroxidase 1) axis to reduce reactive oxygen species accumulation. We also determined that the vascular repair effects of triiodothyronine were Pgc1a-dependent.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We delineate a novel DIO2-mediated adaption in malformed cerebrovasculature and conclude that targeting TH signaling may represent a potential therapy for cerebrovascular disorders.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130314/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130314</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325857>10.1161/CIRCRESAHA.124.325857</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130314</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Ruofei Li</dc:creator>
<dc:creator>Yushan Tang</dc:creator>
<dc:creator>Haiyue Wang</dc:creator>
<dc:creator>Pengyan Hu</dc:creator>
<dc:creator>Liang Yu</dc:creator>
<dc:creator>Cheng Lv</dc:creator>
<dc:creator>Yu Zhang</dc:creator>
<dc:creator>A Martin Gerdes</dc:creator>
<dc:creator>Yibo Wang</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Local DIO2 Elevation Is an Adaption in Malformed Cerebrovasculature</dc:title>
<dc:identifier>pmid:40130314</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325857</dc:identifier>
</item>
<item>
<title>Valve-in-Valve TAVR in Patients With Failed Trifecta Bioprosthetic Aortic Valves</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130310/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Interv. 2025 Mar 25:e014532. doi: 10.1161/CIRCINTERVENTIONS.124.014532. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130310/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130310</a> | DOI:<a href=https://doi.org/10.1161/CIRCINTERVENTIONS.124.014532>10.1161/CIRCINTERVENTIONS.124.014532</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130310</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Mohammad Zmaili</dc:creator>
<dc:creator>Nikolaos Spilias</dc:creator>
<dc:creator>Shivabalan Kathavarayan Ramu</dc:creator>
<dc:creator>Tikal Kansara</dc:creator>
<dc:creator>Akhilesh Khuttan</dc:creator>
<dc:creator>Maryam Muhammad Ali Majeed-Saidan</dc:creator>
<dc:creator>Besir Besir</dc:creator>
<dc:creator>Rohan Prasad</dc:creator>
<dc:creator>Judah Rajendran</dc:creator>
<dc:creator>Feras Alkhalaileh</dc:creator>
<dc:creator>Ahmad Gharaibeh</dc:creator>
<dc:creator>Agam Bansal</dc:creator>
<dc:creator>Abdelrahman Abushouk</dc:creator>
<dc:creator>Serge Harb</dc:creator>
<dc:creator>Rishi Puri</dc:creator>
<dc:creator>Grant Reed</dc:creator>
<dc:creator>James Yun</dc:creator>
<dc:creator>Amar Krishnaswamy</dc:creator>
<dc:creator>Samir Kapadia</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation. Cardiovascular interventions</dc:source>
<dc:title>Valve-in-Valve TAVR in Patients With Failed Trifecta Bioprosthetic Aortic Valves</dc:title>
<dc:identifier>pmid:40130310</dc:identifier>
<dc:identifier>doi:10.1161/CIRCINTERVENTIONS.124.014532</dc:identifier>
</item>
<item>
<title>Many Journeys Originating at the Same Source to Arrive at Solutions to the Common Problem of High Lipoprotein(a)</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130305/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Genom Precis Med. 2025 Mar 25:e005126. doi: 10.1161/CIRCGEN.125.005126. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130305/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130305</a> | DOI:<a href=https://doi.org/10.1161/CIRCGEN.125.005126>10.1161/CIRCGEN.125.005126</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130305</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Jean Woody Luxama</dc:creator>
<dc:creator>Joshua W Knowles</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation. Genomic and precision medicine</dc:source>
<dc:title>Many Journeys Originating at the Same Source to Arrive at Solutions to the Common Problem of High Lipoprotein(a)</dc:title>
<dc:identifier>pmid:40130305</dc:identifier>
<dc:identifier>doi:10.1161/CIRCGEN.125.005126</dc:identifier>
</item>
<item>
<title>Patient-Scientist Perspective on Developing Genetic Therapies for Marfan Syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130304/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Genom Precis Med. 2025 Mar 25:e005114. doi: 10.1161/CIRCGEN.125.005114. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130304/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130304</a> | DOI:<a href=https://doi.org/10.1161/CIRCGEN.125.005114>10.1161/CIRCGEN.125.005114</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130304</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Lauren Testa</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation. Genomic and precision medicine</dc:source>
<dc:title>Patient-Scientist Perspective on Developing Genetic Therapies for Marfan Syndrome</dc:title>
<dc:identifier>pmid:40130304</dc:identifier>
<dc:identifier>doi:10.1161/CIRCGEN.125.005114</dc:identifier>
</item>
<item>
<title>Combined RNA Splicing and Patch-Clamp Analysis Reveal Pathogenicity of Splice-Altering Variants in &lt;em>;KCNH2&lt;/em>;-Related LQTS</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130303/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325181104&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Genom Precis Med. 2025 Mar 25:e004966. doi: 10.1161/CIRCGEN.124.004966. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130303/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325181104&v=2.18.0.post9+e462414">40130303</a> | DOI:<a href=https://doi.org/10.1161/CIRCGEN.124.004966>10.1161/CIRCGEN.124.004966</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130303</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Susan Clasper</dc:creator>
<dc:creator>Gunjan Trivedi</dc:creator>
<dc:creator>Kate L Thomson</dc:creator>
<dc:creator>Claire L S Turner</dc:creator>
<dc:creator>Smrithi Devaiah</dc:creator>
<dc:creator>Catherine L Mercer</dc:creator>
<dc:creator>Amnah Y Bdeir</dc:creator>
<dc:creator>Jumana Y Al-Aama</dc:creator>
<dc:creator>Khalid Dagriri</dc:creator>
<dc:creator>Alex R Hobson</dc:creator>
<dc:creator>Shankar N Sadagopan</dc:creator>
<dc:creator>Julian Ormerod</dc:creator>
<dc:creator>Eszter Szepesvary</dc:creator>
<dc:creator>Justin Phan</dc:creator>
<dc:creator>Diane Fatkin</dc:creator>
<dc:creator>Jamie I Vandenberg</dc:creator>
<dc:creator>Zahurul A Bhuiyan</dc:creator>
<dc:creator>Chai-Ann Ng</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation. Genomic and precision medicine</dc:source>
<dc:title>Combined RNA Splicing and Patch-Clamp Analysis Reveal Pathogenicity of Splice-Altering Variants in &lt;em>;KCNH2&lt;/em>;-Related LQTS</dc:title>
<dc:identifier>pmid:40130303</dc:identifier>
<dc:identifier>doi:10.1161/CIRCGEN.124.004966</dc:identifier>
</item>





























</channel>
</rss>